Anatara Lifesciences (ASX: ANR) Provides GaRP-IBS Trial Update
Anatara Lifesciences updates on its GaRP-IBS trial with promising recruitment numbers and anticipates results in early 2025.
Category: Healthcare
4DMedical Limited (ASX:4DX) Unveils Groundbreaking CT:VQ Technology
4DMedical Limited (ASX:4DX) presents its innovative CT:VQ technology at RSNA 2024, poised to revolutionise lung health diagnostics.
Cynata Therapeutics Limited (ASX:CYP) Requests Trading Halt
Cynata Therapeutics Limited (ASX:CYP) has announced a trading halt pending a significant clinical trial update.
Acrux Limited (ASX:ACR) Receives FDA Approval for Nitroglycerin Ointment
Acrux Limited has received FDA approval for Nitroglycerin Ointment, expanding its portfolio in the topical market.
Pro Medicus Limited (ASX:PME) Co-Founders Sell Shares
Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall sell shares, reaffirming their commitment and retaining significant holdings.
Black Dragon Gold (ASX:BDG) Faces Setback at Salave Project
Black Dragon Gold faces permitting delays as its land re-zoning application for the Salave Gold Project is rejected by local council.
4DMedical Limited (ASX:4DX) Signs Contract with Perth Radiological Clinic
4DMedical Limited announces a contract with Perth Radiological Clinic to enhance lung diagnostics using XV Technology across multiple clinics.
Athena Resources Limited (ASX:AHN) Announces Entitlement Offer
Athena Resources (ASX:AHN) announces a fully underwritten A$2.67 million entitlement offer to fund its Byro Magnetite Project.
Chorus Limited (ASX:CNU) Announces Strategic Reset and FY25 Guidance
Chorus Limited outlines its strategic reset and financial guidance during its Investor Day 2024.
Atturra Limited (ASX:ATA) Completes Acquisition of Plan B
Atturra Limited (ASX:ATA) has completed the acquisition of Plan B, enhancing its managed services and expanding its reach in New Zealand.